Abstract
In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.
| Original language | English |
|---|---|
| Pages (from-to) | 333-337 |
| Journal | Giornale Italiano di Dermatologia e Venereologia |
| Volume | 153 |
| DOIs | |
| Publication status | Published - 2018 |
Keywords
- actinic keratosis
- imiquimod
Fingerprint
Dive into the research topics of 'Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver